» Articles » PMID: 15613339

Infection of Ciliated Cells by Human Parainfluenza Virus Type 3 in an in Vitro Model of Human Airway Epithelium

Overview
Journal J Virol
Date 2004 Dec 23
PMID 15613339
Citations 190
Authors
Affiliations
Soon will be listed here.
Abstract

We constructed a human recombinant parainfluenza virus type 3 (rPIV3) that expresses enhanced green fluorescent protein (GFP) and used this virus, rgPIV3, to characterize PIV3 infection of an established in vitro model of human pseudostratified mucociliary airway epithelium (HAE). The apical surface of HAE was highly susceptible to rgPIV3 infection, whereas only occasional cells were infected when virus was applied to the basolateral surface. Infection involved exclusively ciliated epithelial cells. There was little evidence of virus-mediated cytopathology and no spread of the virus beyond the ciliated cell types. Infection of ciliated cells by rgPIV3 was sensitive to a neuraminidase specific for alpha2-6-linked sialic acid residues, but not to a neuraminidase that cleaves alpha2-3- and alpha2-8-linked sialic acid residues. This provided evidence that rgPIV3 utilizes alpha2-6-linked sialic acid residues for initiating infection, a specificity also described for human influenza viruses. The PIV3 fusion (F) glycoprotein was trafficked exclusively to the apical surface of ciliated cells, which also was the site of release of progeny virus. F glycoprotein localized predominately to the membranes of the cilial shafts, suggesting that progeny viruses may bud from cilia per se. The polarized trafficking of F glycoprotein to the apical surface also likely restricts its interaction with neighboring cells and could account for the observed lack of cell-cell fusion. HAE derived from cystic fibrosis patients was not more susceptible to rgPIV3 infection but did exhibit limited spread of virus due to impaired movement of lumenal secretions due to compromised function of the cilia.

Citing Articles

The Combination of GS-441524 (Remdesivir) and Ribavirin Results in a Potent Antiviral Effect Against Human Parainfluenza Virus 3 Infection in Human Airway Epithelial Cell Cultures and in a Mouse Infection Model.

Lin Y, Weynand B, Zhang X, Laporte M, Jochmans D, Neyts J Viruses. 2025; 17(2).

PMID: 40006927 PMC: 11860817. DOI: 10.3390/v17020172.


A randomized, double-blind, Phase 1, single- and multiple-dose placebo-controlled study of the safety and pharmacokinetics of IN-006, an inhaled antibody treatment for COVID-19 in healthy volunteers.

Moench T, Botta L, Farrer B, Lickliter J, Kang H, Park Y EBioMedicine. 2025; 113:105582.

PMID: 39923743 PMC: 11849668. DOI: 10.1016/j.ebiom.2025.105582.


The structural basis of protective and nonprotective human monoclonal antibodies targeting the parainfluenza virus type 3 hemagglutinin-neuraminidase.

Miller R, Durie I, Gingerich A, Elbehairy M, Branch A, Davis R Nat Commun. 2024; 15(1):10825.

PMID: 39738006 PMC: 11686389. DOI: 10.1038/s41467-024-55101-4.


Development of Primer Panels for Amplicon Sequencing of Human Parainfluenza Viruses Type 1 and 2.

Mansour O, Fadeev A, Perederiy A, Danilenko D, Lioznov D, Komissarov A Int J Mol Sci. 2024; 25(23).

PMID: 39684830 PMC: 11641795. DOI: 10.3390/ijms252313119.


Landscape of respiratory syncytial virus.

Duan Y, Liu Z, Zang N, Cong B, Shi Y, Xu L Chin Med J (Engl). 2024; 137(24):2953-2978.

PMID: 39501814 PMC: 11706595. DOI: 10.1097/CM9.0000000000003354.


References
1.
Pickles R, Fahrner J, Petrella J, Boucher R, Bergelson J . Retargeting the coxsackievirus and adenovirus receptor to the apical surface of polarized epithelial cells reveals the glycocalyx as a barrier to adenovirus-mediated gene transfer. J Virol. 2000; 74(13):6050-7. PMC: 112103. DOI: 10.1128/jvi.74.13.6050-6057.2000. View

2.
Nguyen D, Hildreth J . Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol. 2000; 74(7):3264-72. PMC: 111827. DOI: 10.1128/jvi.74.7.3264-3272.2000. View

3.
Feldman S, Audet S, Beeler J . The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate. J Virol. 2000; 74(14):6442-7. PMC: 112152. DOI: 10.1128/jvi.74.14.6442-6447.2000. View

4.
Capdeville Y . Paramecium GPI proteins: variability of expression and localization. Protist. 2000; 151(2):161-9. DOI: 10.1078/1434-4610-00016. View

5.
Hallak L, Spillmann D, Collins P, Peeples M . Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J Virol. 2000; 74(22):10508-13. PMC: 110925. DOI: 10.1128/jvi.74.22.10508-10513.2000. View